These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 18063845

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response.
    Thondam SK, Daousi C, Wilding JP, Holst JJ, Ameen GI, Yang C, Whitmore C, Mora S, Cuthbertson DJ.
    Am J Physiol Endocrinol Metab; 2017 Mar 01; 312(3):E224-E233. PubMed ID: 28073779
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Meal test for glucose-dependent insulinotropic peptide (GIP) in obese and type 2 diabetic patients.
    Skrha J, Hilgertová J, Jarolímková M, Kunešová M, Hill M.
    Physiol Res; 2010 Mar 01; 59(5):749-755. PubMed ID: 20406045
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells.
    Almind K, Ambye L, Urhammer SA, Hansen T, Echwald SM, Holst JJ, Gromada J, Thorens B, Pedersen O.
    Diabetologia; 1998 Oct 01; 41(10):1194-8. PubMed ID: 9794107
    [Abstract] [Full Text] [Related]

  • 9. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ.
    J Clin Endocrinol Metab; 2003 Oct 01; 88(10):4897-903. PubMed ID: 14557471
    [Abstract] [Full Text] [Related]

  • 10. The equine glucose-dependent insulinotropic polypeptide receptor: A potential therapeutic target for insulin dysregulation.
    Kheder MH, Sillence MN, Bryant LM, de Laat MA.
    J Anim Sci; 2017 Jun 01; 95(6):2509-2516. PubMed ID: 28727072
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist.
    Lewis JT, Dayanandan B, Habener JF, Kieffer TJ.
    Endocrinology; 2000 Oct 01; 141(10):3710-6. PubMed ID: 11014226
    [Abstract] [Full Text] [Related]

  • 15. Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
    Irwin N, McClean PL, O'Harte FP, Gault VA, Harriott P, Flatt PR.
    Diabetologia; 2007 Jul 01; 50(7):1532-40. PubMed ID: 17486314
    [Abstract] [Full Text] [Related]

  • 16. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
    Hira T, Koga T, Sasaki K, Hara H.
    Biochem Biophys Res Commun; 2017 Oct 14; 492(2):161-165. PubMed ID: 28803984
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic desensitization of the glucose-dependent insulinotropic polypeptide receptor in diabetic rats.
    Tseng CC, Boylan MO, Jarboe LA, Usdin TB, Wolfe MM.
    Am J Physiol; 1996 Apr 14; 270(4 Pt 1):E661-6. PubMed ID: 8928774
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide.
    Gault VA, O'Harte FP, Harriott P, Flatt PR.
    Biochem Biophys Res Commun; 2002 Feb 08; 290(5):1420-6. PubMed ID: 11820780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.